Overview


According to FutureWise analysis, the market for Regenerative Medicine in 2023 is US$ 15.55 billion, and is expected to reach US$ 108.02 billion by 2031 at a CAGR of 27.40%.  

Regenerative medicine refers to a medical field that concentrates on the restoration, regeneration, and substitution of damaged or diseased tissues and organs. Regenerative medicine aims to prompt the body's innate healing mechanisms or employ cutting-edge technologies such as tissue engineering and stem cells to revive damaged tissues and organs, ultimately restoring their normal functions. Stem cells are a critical component of regenerative medicine as they possess the potential to develop into diverse cell types, including bone cells, muscle cells, and nerve cells. Stem cells can be achieved from numerous sources, such as embryos, adult tissues, and umbilical cord blood. Scientists can manipulate stem cells in the lab to produce specific types of cells and tissues, which are used to treat various medical conditions.

Tissue engineering is another critical aspect of regenerative medicine. This involves growing tissues or organs in the lab using a combination of cells, biomaterials, and biochemical signals. Tissue engineering can be used to produce replacement tissues or organs for transplant, such as skin, cartilage, and heart valves. Gene therapy is also a promising area of regenerative medicine. Genetic engineering is a technique used to introduce foreign genetic material into cells. This approach can be utilized to rectify genetic abnormalities or activate the body's inherent healing mechanisms. This technique has the ability to treat a variety of genetic disorders, such as sickle cell anemia, cystic fibrosis, and hemophilia. Regenerative medicine has the ability to revolutionize the treatment of various medical conditions, including chronic diseases, degenerative disorders, and injuries. By repairing or replacing damaged tissues and organs, regenerative therapies offer the potential for long-lasting and even permanent solutions to these conditions, improving patient outcomes and quality of life.

FutureWise Market Research has published a report that provides an insightful analysis of Regenerative Medicine Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that Regenerative Medicine Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Acelity Holdings, Inc.
  • Athersys, Inc.
  • Cryolife, Inc.
  • Integra Lifesciences Corporation
  • Isto Biologics
  • Medtronic Plc.
  • Organogenesis Inc.
  • Stryker Corporation
  • U.S. Stem Cell, Inc.
  • Zimmer Biomet Holdings, Inc.

Recent developments by key players in Regenerative Medicine Market:

In April 2022, The U.S. FDA granted the Regenerative Medicine Advanced Therapy designation to obecabatagene autoleucel, a CD19-directed autologous chimeric antigen receptor T therapy that Autolus Therapeutics plc identifies as its primary gene therapy. This treatment is being tested in the ongoing FELIX Phase 2 study of leukaemia.

The field of regenerative medicine has experienced significant expansion in recent years, driven by numerous factors, including advancements in stem cell research, gene therapy, tissue engineering, and biomaterials development. Regenerative medicine offers promising solutions for a wide range of medical conditions, including chronic diseases, degenerative disorders, and injuries, by replacing or repairing damaged tissues and organs. One of the key drivers of the regenerative medicine market is the increasing prevalence of chronic diseases, such as cancer, diabetes, and CVDs. According to the World Health Organization (WHO), chronic diseases are responsible for 70% of all deaths worldwide, highlighting the need for effective treatments. Regenerative medicine offers the potential to treat these conditions by replacing or repairing damaged tissues or organs, providing a more permanent solution than current treatments. Another driver of the regenerative medicine market is the growing aging population. With growing age, individuals are more prone to chronic ailments and degenerative conditions, resulting in an increased need for regenerative treatments. Moreover, the increasing prevalence of injuries caused by accidents and trauma is also contributing to the growth of the regenerative medicine market. Regenerative therapies offer the potential to repair damaged tissues and organs, leading to better outcomes and faster recovery times than traditional treatments.

However, despite the significant growth potential, the regenerative medicine market faces several challenges, including the high cost of research and development, ethical concerns, and regulatory hurdles. Additionally, the commercialization of regenerative therapies requires significant investment, which may limit the availability of these treatments to patients.

By Product Type

  • Cell Therapy
  • Gene Therapy
  • Tissue Engineering
  • Small Molecule & Biologic

By Material

  • Synthetic Material
    • Biodegradable Synthetic Polymer
    • Scaffold
    • Artificial Vascular Graft Material
    • Hydrogel Material
  • Biologically Derived Material
    • Collagen
    • Xenogeneic Material
  • Genetically Engineered Material
    • Deoxyribonucleic Acid Transfection Vector
    • Genetically Manipulated Cell
    • Three-Dimensional Polymer Technology
    • Transgenic
    • Fibroblast
    • Neural Stem Cell
    • Gene-Activated Matrices
  • Pharmaceuticals
    • Small Molecule
    • Biologic

By Application

  • Cardiovascular
  • Oncology
  • Dermatology
  • Musculoskeletal
  • Wound Healing
  • Ophthalmology
  • Neurology
  • Others

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

 By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. Additionally, in 2022, the global market for    regenerative medicines saw North America leading with a share of over 51%. The significant growth in the regenerative medicines market is due to the presence of major industry players, rapid technological advancements, and substantial investments in stem cell and oncology research. The U.S. holds the largest market share in North America, mainly due to the increasing incidence of chronic illnesses such as diabetes, CVDs, and cancer that can benefit from stem cell therapies. This presents a significant opportunity for market players who are focusing on research and development to introduce new stem cell therapies and drive growth in the industry. Overall, these factors are expected to fuel market expansion in the region throughout the forecast period. 

  • Tier 1 players- established companies in the market with major market share
  • Tier 2 players
  • New Entrants
  • Emerging players which are growing rapidly

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data points affecting market growth

  • To provide with an exhaustive analysis on the Regenerative Medicine Market By Product Type, By Material, By Application and By Region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represented in the format of data-sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches.

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Regenerative Medicine Market Variables, Trends
    • Scope
        1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances
  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Regenerative Medicine Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Regenerative Medicine Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Regenerative Medicine Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Cell Therapy
        2. Gene Therapy
        3. Tissue Engineering
        4. Small Molecule & Biologic

  • 8.   Regenerative Medicine Market, By Material Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Synthetic Material
         1.1. Biodegradable Synthetic Polymer
         1.2. Scaffold
         1.3. Artificial Vascular Graft Material
         1.4. Hydrogel Material
        2. Biologically Derived Material
         2.1. Collagen
         2.2. Xenogeneic Material
        3. Genetically Engineered Material
         3.1. Deoxyribonucleic Acid Transfection Vector
         3.2. Genetically Manipulated Cell
         3.3. Three-Dimensional Polymer Technology
         3.4. Transgenic
         3.5. Fibroblast
         3.6. Neural Stem Cell
         3.7. Gene-Activated Matrices
        4. Pharmaceuticals
         4.1. Small Molecule
         4.2. Biologic

  • 9.   Regenerative Medicine Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Cardiovascular
        2. Oncology
        3. Dermatology
        4. Musculoskeletal
        5. Wound Healing
        6. Ophthalmology
        7. Neurology
        8. Others

  • 10.   North America Regenerative Medicine Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Regenerative Medicine Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Regenerative Medicine Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Regenerative Medicine Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •   1. Acelity Holdings, Inc.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
          2. Athersys, Inc.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
          3. Cryolife, Inc.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
         4. Integra Lifesciences Corporation
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
          5. Isto Biologics
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
          6. Medtronic Plc.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
          7. Organogenesis Inc.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
          8. Stryker Corporation
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
          9. U.S. Stem Cell, Inc.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
         10. Zimmer Biomet Holdings, Inc.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact

    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by Cryolife, 
                  Inc.inistrations
        5. The overall economic slowdown of the developing and developed nations

  • 18.   FutureWise SME Key Takeaway Points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11